 BERKELEY HEIGHTS, N.J. , Nov. 02, 2022 GLOBE NEWSWIRE -- CorMedix Inc. Nasdaq: CRMD, a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the market open on Thursday, November 10, 2022, and will host a corporate update conference call at 8:30am Eastern Time. 